(Q38542962)

4 September 2017

1 reference

title

Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review (English)

1 reference

4 September 2017

1

Mark Jit

1 reference

4 September 2017

Walter Mibei

2

1 reference

4 September 2017

language of work or name

English

0 references

publication date

2 July 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

33

1 reference

4 September 2017

issue

32

1 reference

4 September 2017

page(s)

3788-3794

1 reference

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Discounting in the economic evaluation of health care interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Time Discounting and Time Preference: A Critical Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Need for differential discounting of costs and health effects in cost effectiveness analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

A fair approach to discounting future effects: taking a societal perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Discounting, preferences, and paternalism in cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Discounting for health effects in cost-benefit and cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Discounting and decision making in the economic evaluation of health-care technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Discounting costs and effects: a reconsideration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Discounting: technical issues in economic evaluations of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Discounting health effects in pharmacoeconomic evaluations: current controversies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

On discounting of health gains from human papillomavirus vaccination: effects of different approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Do we fully understand the economic value of vaccines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Economic evaluation of human papillomavirus vaccination in developed countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Economic evaluations of Haemophilus influenzae type b vaccine: systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Economic Evaluations of Childhood Influenza Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Cost effectiveness of rotavirus vaccination in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

A Mathematical Theory of Saving

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Methods of international health technology assessment agencies for economic evaluations--a comparative analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

WHO Guide for standardisation of economic evaluations of immunization programmes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

NICE's selective application of differential discounting: ambiguous, inconsistent, and unjustified.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

The discount rate in the economic evaluation of prevention: a thought experiment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Discounting in cost-utility analysis of healthcare interventions: reassessing current practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

7 January 2021

Valuing future benefits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Understanding DALYs (disability-adjusted life years)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

The discounting of lives saved in future generations--some empirical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Differential time preferences for money and quality of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Golden Eggs and Hyperbolic Discounting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Time Preference for Health: A Test of Stationarity versus Decreasing Timing Aversion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Utility model of preventive behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Negative and zero time preference for health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Status quo bias in decision making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Practical implications of differential discounting in cost-effectiveness analyses with varying numbers of cohorts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

Time preference for health in cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.06.084

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2015.06.084

1 reference

4 September 2017

1 reference